Sunscreen industry stakeholders facing the potential loss of UV filters under FDA’s OTC drug review could have much to gain from the antibacterial soap sector, which is about halfway into a five-year work plan to keep priority germ-killing ingredients available on an OTC basis.
The Consumer Healthcare Products Association is drafting comments on the Food and Drug Administration’s proposed sunscreen rule issued in late February
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?